Tenidap inhibits replication of the human immunodeficiency virus-1 and downregulates HIV long terminal repeat (LTR)-driven gene expression in cultured cells: Christoph M. Ahlers∗, Bruce J. Dezube∗, John P. Lawrence†, Sandra L. Silberman§, Arthur B. Pardee∗, and Robert W. Finberg†. ∗Divisions of Cell Growth & Regulation and †Infectious Diseases, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; §Central Research Division, Pfizer Inc., Groton, CT, USA